Bacterial Meningitis
-
{
- All
- News
-
21-Year-Old Dies After Contracting Aggressive Form Of Meningococcal B; What You Should Know About The Fatal Infection
Neisseria meningitidis, also known as Meningococcal, is a type of bacterial meningitis. There are different strains of Meningococcal, which affects teenagers and young adults.
-
Kent Meningitis Outbreak Not Officially Contained Yet, Risk Of Secondary Infections High: What Secondary Infections Mean, Disease Progression Explained
Meningitis, especially the bacterial form linked to this outbreak, can progress rapidly.
-
Understanding The Long-Term Effects Of Meningitis: Rehabilitation And Recovery
In this article, we will explore the long-term effects of meningitis and discuss the rehabilitation and recovery processes crucial for improving outcomes.
-
Cost of Bacterial Meningitis Vaccine Reduced
Hilleman Laboratories has made developments with respect to increased efficacy and reduced cost of Bacterial Meningitis vaccine and published a scientific report based on the synthesis of the meningitis vaccine for Neisseria Meningitidis serogroup X.
-
Meningitis vaccine provides lasting protection
The meningitis C vaccine program introduced in the UK in 1999 has been successful in bringing down disease rates. A recent study indicates that vaccine remains effective 4 years later, provided that it was given at the appropriate age.
-
21-Year-Old Dies After Contracting Aggressive Form Of Meningococcal B; What You Should Know About The Fatal Infection
Neisseria meningitidis, also known as Meningococcal, is a type of bacterial meningitis. There are different strains of Meningococcal, which affects teenagers and young adults.
-
Kent Meningitis Outbreak Not Officially Contained Yet, Risk Of Secondary Infections High: What Secondary Infections Mean, Disease Progression Explained
Meningitis, especially the bacterial form linked to this outbreak, can progress rapidly.
-
Understanding The Long-Term Effects Of Meningitis: Rehabilitation And Recovery
In this article, we will explore the long-term effects of meningitis and discuss the rehabilitation and recovery processes crucial for improving outcomes.
-
Cost of Bacterial Meningitis Vaccine Reduced
Hilleman Laboratories has made developments with respect to increased efficacy and reduced cost of Bacterial Meningitis vaccine and published a scientific report based on the synthesis of the meningitis vaccine for Neisseria Meningitidis serogroup X.
-
Meningitis vaccine provides lasting protection
The meningitis C vaccine program introduced in the UK in 1999 has been successful in bringing down disease rates. A recent study indicates that vaccine remains effective 4 years later, provided that it was given at the appropriate age.
